Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Peptide-conjugated morpholino oligomers effectively inhibit SARS-CoV-2 in vero cells

The hunt for antivirals has reached an unprecedented pace in light of the coronavirus 2019 (COVID-19) pandemic. The causal agent for this disease – severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – has already infected over 52 million people worldwide, and has subsequently claimed over 1.3 million lives. However, among the innumerable promising drug candidates that help battle the virus and mitigate its damage, none have yet made it to the clinic.

12 Nov 2020

Rhesus monkeys and cats potential spillover reservoirs for COVID-19 virus

A team of researchers from Switzerland, Costa Rica and Germany has conducted a study showing which animal species could potentially serve as spillback reservoirs of severe acute repertory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

12 Nov 2020

"Cat's claw" extract inhibits replication of SARS-CoV-2 in vitro

Researchers in Columbia and Peru have shown that Uncaria tomentosa – a woody vine native to South America known of as "Cat's claw" – exerts in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).

12 Nov 2020

Antidepressant drug fluvoxamine may prevent some serious complications of COVID-19

In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.

12 Nov 2020

KHN’s ‘What the Health?’: Transition interrupted

Five days after the election was called for President-elect Joe Biden, President Donald Trump has not conceded — and instead ordered his administration not to begin the transition of power.

12 Nov 2020

Pollution may bear part of the blame for rapid spread SARS-CoV-2 in the U.S.

The United States may have set itself up for the spread of a pandemic without even knowing it.

12 Nov 2020

Common spike mutation may make SARS-CoV-2 more susceptible to a vaccine

A new study published in Science confirms that SARS-CoV-2 has mutated in a way that's enabled it to spread quickly around the world, but the spike mutation may also make the virus more susceptible to a vaccine.

12 Nov 2020

Workers who lost jobs due to COVID may need help getting coverage this fall

Michelina Moen lost her job and health insurance in April. Only weeks earlier she had begun to feel ill and not her usual energetic self — in what she describes as a textbook case of "really bad timing."

12 Nov 2020

Nursing homes still see dangerously long waits for COVID test results

Nursing homes are still taking days to get back COVID-19 test results as many shun the Trump administration's central strategy to limit the spread of the virus among old and sick Americans.

12 Nov 2020

Listen: COVID stresses rural hospitals already ‘teetering on the brink’

When KHN Editor-in-Chief Elisabeth Rosenthal heard a sample of the voices that correspondent Sarah Jane Tribble brought back from her reporting trip to rural Kansas, Rosenthal said she knew the story needed to be told through audio.

12 Nov 2020

London-based Veraco launches product range to reduce microbes on frequently touched surfaces

London based Veraco has designed and manufactured a range of Antimicrobial adhesive pads and wraps to be used on frequently touched surfaces, such as door handles, shopping trolleys and handrails.

12 Nov 2020

Beckman Coulter introduces new SARS-CoV-2 IgM assay in countries accepting the CE Mark

Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M assay in countries accepting the CE Mark.

From Beckman Coulter Diagnostics 12 Nov 2020

IMCRC launches new funding initiative with an Australian first rapid COVID-19 test

Innovative Manufacturing Cooperative Research Centre (IMCRC) has launched its new funding initiative, IMCRC activate, with an Australian first — the development of a rapid COVID-19 test that uses optical technology.

12 Nov 2020

New £2 million project to improve lives of dementia carers in the UK

Researchers at the University of East Anglia and Norfolk and Suffolk NHS Foundation Trust are launching a new project to improve the lives of dementia carers in the UK.

12 Nov 2020

New process helps preserve viral vaccines without refrigeration

Ever receive a vaccination that seemed to burn a lot while it was injected? The vaccine solution likely contained a lot of salt or sugar - natural preservatives that help keep it stable, in addition to the cold temperature at which it was kept.

12 Nov 2020

Routine testing for COVID-19 before major surgery could reduce risk of respiratory complications

Routine testing patients for COVID-19 before major surgery could reduce the risk of respiratory complications and save lives, a new study reveals.

12 Nov 2020

COVID-19 treatments for people with early infection should be prioritized

COVID-19 treatments for people with early infection are needed urgently, according to a JAMA Viewpoint article by National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., and colleagues.

11 Nov 2020

Disinfectants with "virucidal activity against enveloped viruses" effective against SARS-CoV-2

A recent study demonstrated that two commercially available surface disinfectant formulations and one hand disinfection formulation that claim "virucidal activity against enveloped viruses" are effective in inactivating the SARS-CoV-2 virus. Their study has been published on the preprint server bioRxiv.

11 Nov 2020

Researchers identify acrylamides that inhibit SARS-CoV-2 main protease

A new study in the preprint server bioRxiv published in November 2020 describes the discovery of acrylamide fragments that can effectively disable key enzymes in both the hand, foot and mouth virus and SARS-CoV-2 virus.

11 Nov 2020

Human coronaviruses cause processing body loss

Researchers continue to expand their knowledge of coronaviruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. Now, a new study published on the preprint server bioRxiv in November 2020 describes a vital mechanism whereby the novel SARS-CoV-2 pathogen can restrict the human host response. In doing so, the study explores how this novel feature of SARS-CoV-2 works and how it results in a reshaping of the human host's immune response.

11 Nov 2020